Advertisement
Research Article

Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

  • Kristen M. Kahle,

    Affiliation: Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • H. Kirby Steger,

    Affiliation: Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    Current address: Department of Protein Therapeutics Development, Bristol-Myers-Squibb, Pennington, New Jersey, United States of America

    X
  • Michael J. Root mail

    michael.root@jefferson.edu

    Affiliation: Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Published: November 26, 2009
  • DOI: 10.1371/journal.ppat.1000674

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.